Comparing blood clotting tests for clotting factor deficiencies
Part of Blood & lymphatic clinical trials.
This trial compares different blood test reagents to see which works best for measuring clotting time in people with clotting factor deficiencies or liver disease. It may help doctors choose the right test for your condition.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You have a deficiency in one of the clotting factors II, V, VII, or X (or a combination).
- You are not taking any oral blood thinners (like warfarin or apixaban).
- You are not taking injected blood thinners except for standard low-dose heparin.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial uses stored blood samples to see how well different lab tests measure clotting when someone has a factor deficiency (like low levels of clotting proteins) or liver damage. It may help doctors choose the most accurate test for these situations.
This trial tests a new lab device that measures how well your body forms primary blood clots while blood is kept in flowing conditions. It may help doctors better assess bleeding or clotting tendencies and guide future care.
This study tests a new quick blood-clotting test (point-of-care INR testing) for patients with antiphospholipid syndrome who take blood thinners. The goal is to see if this faster test works as well as standard lab tests for monitoring their treatment.
This trial measures normal blood clotting (hemostasis) in infants up to 18 months old, especially premature babies. It helps doctors understand typical clotting levels to improve care.
This study measures how long it takes for your blood to clot while you are taking anticoagulant medication. The purpose is to understand typical clotting times for patients on these drugs, which may help improve future monitoring or treatment decisions.
This Phase 4 study looks at how clotting measurements relate to bleeding risk in people with liver cirrhosis who need a planned liver procedure. The study may help doctors understand what coagulation results mean when doing these procedures safely.
Hear when a new Hemorrhagic Disorders trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.